Furthermore, a direct comparison demonstrated that [99mTc]Tc-ADAPT6 provides higher uptake (SUVmax) in HER2-positive breast cancer lesions than 99mTc-labeled DARPin G3 [23], when both tracers were injected with an optimal mass and imaging was performed at the optimal time point for each tracer. This evidence concerns the gene ERBB2 and breast carcinoma.